HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysisResearch in context
Summary: Background: Glatiramer acetate (GA) is a well-tolerated treatment for multiple sclerosis (MS) and comparable in its efficacy to high-dose interferon beta (IFN). As a lack of validated treatment response biomarkers for MS hampers progress in personalised treatment, the study goal was to sea...
Saved in:
Similar Items
-
Incremental Capacity and Voltammetry of Batteries, and Implications for Electrochemical Impedance Spectroscopy
by: Christopher Dunn, et al.
Published: (2025-06-01) -
Business policy: text and cases
by: Christensen, C. Roland (Carl Roland), 1919-
Published: (1973) -
Teaching and the case method : text, cases, and readings /
by: Christensen, C. Roland
Published: (1987) -
Selective digestive tract decontamination in the intensive care unit: Life saver or recipe for disaster?
by: J.S. Davis, et al.
Published: (2025-06-01) -
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
by: Valerie A J Block, et al.
Published: (2016-01-01)